Showing results (231-240 of 280) with videos related to
Sort By:
Pageof 28
Nature Communications|March 11, 2023
Clinical NEC prevention practices drive different microbiome profiles and functional responses in the preterm intestineCharlotte J Neumann, Alexander Mahnert, Christina Kumpitsch, et al.Pediatric Surgery International|April 19, 2003
Gastroschisis: determinants of neonatal outcomeS J Singh, A Fraser, J F Leditschke, et al.ACS Applied Materials & Interfaces|August 8, 2024
Nanotopography Influences Host-Pathogen Quorum Sensing and Facilitates Selection of Bioactive Metabolites in Mesenchymal Stromal Cells and Pseudomonas aeruginosa Co-CulturesRosalia Cuahtecontzi Delint, Mohd I Ishak, Penelope M Tsimbouri, et al.Journal of the American Heart Association|January 13, 2017
Predictors of Nonuse of a High-Potency Statin After an Acute Coronary Syndrome: Insights From the Stabilization of Plaques Using Darapladib-Thrombolysis in Myocardial Infarction 52 (SOLID-TIMI 52) TrialAlon Eisen, Christopher P Cannon, Eugene Braunwald, et al.Biomaterials Advances|October 23, 2025
Global metabolomics identifies new extracellular biomarkers of nanovibration-driven mesenchymal stem cells osteodifferentiationDaniela S C Bispo, Inês Graça, Jennifer H Haggarty, et al.Scientific Reports|November 29, 2017
Towards the cell-instructive bactericidal substrate: exploring the combination of nanotopographical features and integrin selective synthetic ligandsRoberta Fraioli, Penelope M Tsimbouri, Leanne E Fisher, et al.Advanced Healthcare Materials|February 19, 2016
Analysis of Osteoclastogenesis/Osteoblastogenesis on Nanotopographical Titania SurfacesRobert K Silverwood, Paul G Fairhurst, Terje Sjöström, et al.Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences|April 18, 2018
Control of cell behaviour through nanovibrational stimulation: nanokickingShaun N Robertson, Paul Campsie, Peter G Childs, et al.ACS Applied Materials & Interfaces|July 8, 2020
Nanopatterned Titanium Implants Accelerate Bone Formation In VivoAndrew I M Greer, Vitali Goriainov, Janos Kanczler, et al.Circulation|February 15, 2015
Vorapaxar in patients with diabetes mellitus and previous myocardial infarction: findings from the thrombin receptor antagonist in secondary prevention of atherothrombotic ischemic events-TIMI 50 trialMatthew A Cavender, Benjamin M Scirica, Marc P Bonaca, et al.Pageof 28